Literature DB >> 26656888

Inhibiting bacterial toxins by channel blockage.

Sergey M Bezrukov1, Ekaterina M Nestorovich2.   

Abstract

Emergent rational drug design techniques explore individual properties of target biomolecules, small and macromolecule drug candidates, and the physical forces governing their interactions. In this minireview, we focus on the single-molecule biophysical studies of channel-forming bacterial toxins that suggest new approaches for their inhibition. We discuss several examples of blockage of bacterial pore-forming and AB-type toxins by the tailor-made compounds. In the concluding remarks, the most effective rationally designed pore-blocking antitoxins are compared with the small-molecule inhibitors of ion-selective channels of neurophysiology. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  channel-blocking antitoxins; multivalent interactions; physical forces of efficient blockage; rational drug design; single molecule/protein interaction; structure-based drug discovery

Mesh:

Substances:

Year:  2015        PMID: 26656888      PMCID: PMC4830228          DOI: 10.1093/femspd/ftv113

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  112 in total

1.  Stochastic sensing of organic analytes by a pore-forming protein containing a molecular adapter.

Authors:  L Q Gu; O Braha; S Conlan; S Cheley; H Bayley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

Review 2.  Membrane translocation by anthrax toxin.

Authors:  R John Collier
Journal:  Mol Aspects Med       Date:  2009-06-27

Review 3.  The unfolding story of anthrax toxin translocation.

Authors:  Katie L Thoren; Bryan A Krantz
Journal:  Mol Microbiol       Date:  2011-03-28       Impact factor: 3.501

4.  Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Mahtab Moayeri; Stephen H Leppla; Sergey M Bezrukov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

5.  Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Adiamseged Yohannes; Tanisha M Robinson; Nour Eddine Fahmi; Frank Schmidtmann; Sidney M Hecht; Sergey M Bezrukov
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

6.  The staphylococcal leukocidin bicomponent toxin forms large ionic channels.

Authors:  G Miles; S Cheley; O Braha; H Bayley
Journal:  Biochemistry       Date:  2001-07-24       Impact factor: 3.162

7.  The protective antigen component of anthrax toxin forms functional octameric complexes.

Authors:  Alexander F Kintzer; Katie L Thoren; Harry J Sterling; Ken C Dong; Geoffrey K Feld; Iok I Tang; Teri T Zhang; Evan R Williams; James M Berger; Bryan A Krantz
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

8.  Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxin.

Authors:  Alexander E Lang; Tobias Neumeyer; Jianjun Sun; R John Collier; Roland Benz; Klaus Aktories
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

9.  Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity.

Authors:  B G Stiles; T D Wilkins
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

Review 10.  Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.

Authors:  Valère Lounnas; Tina Ritschel; Jan Kelder; Ross McGuire; Robert P Bywater; Nicolas Foloppe
Journal:  Comput Struct Biotechnol J       Date:  2013-04-02       Impact factor: 7.271

View more
  6 in total

1.  Blocker escape kinetics from a membrane channel analyzed by mapping blocker diffusive dynamics onto a two-site model.

Authors:  Alexander M Berezhkovskii; Sergey M Bezrukov
Journal:  J Chem Phys       Date:  2019-05-21       Impact factor: 3.488

2.  Exploring the Nature of Cationic Blocker Recognition by the Anthrax Toxin Channel.

Authors:  Sanaz Momben Abolfath; Michelle Kolberg; Vladimir A Karginov; Stephen H Leppla; Ekaterina M Nestorovich
Journal:  Biophys J       Date:  2019-09-12       Impact factor: 4.033

Review 3.  Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection.

Authors:  Tamara Escajadillo; Victor Nizet
Journal:  Toxins (Basel)       Date:  2018-12-17       Impact factor: 4.546

4.  A Monoclonal Antibody against the C-Terminal Domain of Bacillus cereus Hemolysin II Inhibits HlyII Cytolytic Activity.

Authors:  Natalia Rudenko; Alexey Nagel; Anna Zamyatina; Anna Karatovskaya; Vadim Salyamov; Zhanna Andreeva-Kovalevskaya; Alexander Siunov; Alexander Kolesnikov; Anna Shepelyakovskaya; Khanafiy Boziev; Bogdan Melnik; Fedor Brovko; Alexander Solonin
Journal:  Toxins (Basel)       Date:  2020-12-19       Impact factor: 4.546

5.  Liposomes Prevent In Vitro Hemolysis Induced by Streptolysin O and Lysenin.

Authors:  Marcelo Ayllon; Gamid Abatchev; Andrew Bogard; Rosey Whiting; Sarah E Hobdey; Daniel Fologea
Journal:  Membranes (Basel)       Date:  2021-05-18

Review 6.  Inhibition of Pore-Forming Proteins.

Authors:  Neža Omersa; Marjetka Podobnik; Gregor Anderluh
Journal:  Toxins (Basel)       Date:  2019-09-19       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.